fusidinsyre/hydrocortisonacetat "2care4" 10+20 mg/g creme
2care4 aps - fusidinsyre, hydrocortisonacetat - creme - 10+20 mg/g
colifoam 100 mg/dosis rektalskum
viatris aps - hydrocortisonacetat - rektalskum - 100 mg/dosis
colifoam 100 mg/dosis rektalskum
orifarm a/s - hydrocortisonacetat - rektalskum - 100 mg/dosis
hydrocortison m.terramycin+polymyxin-b 15 + 5 + 1 mg/ml øjen- og øredråber, suspension
pfizer aps - hydrocortisonacetat, oxytetracyclinhydrochlorid, polymyxin b sulfat - øjen- og øredråber, suspension - 15 + 5 + 1 mg/ml
hydropol 15 + 5 + 1 mg/ml øjen- og øredråber, suspension
2care4 aps - hydrocortisonacetat, oxytetracyclinhydrochlorid, polymyxin b sulfat - øjen- og øredråber, suspension - 15 + 5 + 1 mg/ml
cortinova b 15 + 5 + 1 mg/ml øjen- og øredråber, suspension
paranova danmark a/s - hydrocortisonacetat, oxytetracyclinhydrochlorid, polymyxin b sulfat - øjen- og øredråber, suspension - 15 + 5 + 1 mg/ml
terraxin 15 + 5 + 1 mg/ml øjen- og øredråber, suspension
nordic prime aps - hydrocortisonacetat, oxytetracyclinhydrochlorid, polymyxin b sulfat - øjen- og øredråber, suspension - 15 + 5 + 1 mg/ml
fucidin-hydrocortison 10+20 mg/g creme
leo pharma a/s - fusidinsyre, hydrocortisonacetat - creme - 10+20 mg/g
colifoam 100 mg/dosis rektalskum
2care4 aps - hydrocortisonacetat - rektalskum - 100 mg/dosis
protopic
leo pharma a/s - tacrolimus - dermatitis, atopisk - andre dermatologiske præparater - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. der forekommer fire eller flere gange om året), der har haft en indledende reaktion på højst seks uger behandling af to gange dagligt tacrolimus salve (læsioner ryddet, næsten ryddet eller let påvirket).